Related Experiment Video
Updated: Nov 3, 2025

The Soft Agar Colony Formation Assay
Published on: October 27, 2014
SOX17 Antagonizes the WNT Signaling Pathway and is Epigenetically Inactivated in Clear-Cell Renal Cell Carcinoma
Lu Wang1, Zhe Wang2, Yuze Zhu1
1Department of Urology, Shengjing Hospital of China Medical University, Shenyang, 110004, People's Republic of China.
Background:
SRY-box containing gene 17 (SOX17) was reported to be a candidate tumor suppressor gene in multiple tumors. Little is known about its role in clear-cell renal cell carcinoma (ccRCC). This study aims to identify the epigenetic regulation and tumor-suppressive function of SOX17 in ccRCC.
Patients And Methods:
Fifty-five human ccRCC tissue samples, ten adjacent non-malignant kidney tissue samples, 20 paired paraffin section tissues and seven RCC cell lines were obtained. Immunohistochemistry (IHC) and real-time PCR were used to examine the expression of the target genes at the mRNA and protein levels. The methylation of SOX17 was analyzed using methylation-specific PCR (MSP) and bisulfite genomic sequencing (BGS) assay. The functions of SOX17 were examined by using CCK8, colony formation, wound healing assay and Matrigel invasion assays. Luciferase assay was used to analyze the function of SOX17 in the WNT signaling pathway.
Results:
We investigated the SOX17 expression in ccRCC tissues and adjacent non-malignant kidney tissues using PCR and IHC. The expression of SOX17 was lower in ccRCC tissues. Next, we analyzed the DNA promoter methylation of SOX17 in 55 human ccRCC tissues, 10 adjacent non-malignant kidney tissues and RCC cell lines using MSP. DNA methylation of the SOX17 promoter region occurred in 60% of ccRCC tissues and 10% of adjacent non-malignant kidney tissues. In vitro experiments showed that SOX17 suppressed the proliferation of RCC cells. Furthermore, SOX17 inhibited the migration of RCC cells as shown in the wound healing and migration assays. In addition, we found that SOX17 overexpression affected the WNT signaling pathway by downregulating c-myc and cyclinD1.
Conclusion:
In summary, our study showed that SOX17 is downregulated in ccRCC and the loss of SOX17 expression is regulated via epigenetic mechanisms in ccRCC. In addition, SOX17 negatively regulates the WNT signaling pathway and function as a tumor suppressor in ccRCC.
Insights
SRY-box containing gene 17 (SOX17) is downregulated in clear-cell renal cell carcinoma (ccRCC) due to epigenetic silencing. SOX17 acts as a tumor suppressor by inhibiting ccRCC cell proliferation and migration, and negatively regulating the WNT pathway.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- SRY-box containing gene 17 (SOX17) is a known tumor suppressor in various cancers.
- Its role in clear-cell renal cell carcinoma (ccRCC) remains largely unexplored.
- This study investigates the epigenetic regulation and tumor-suppressive functions of SOX17 in ccRCC.
Purpose of the Study:
- To determine the expression levels of SOX17 in ccRCC tissues and cell lines.
- To investigate the epigenetic mechanisms, specifically DNA promoter methylation, regulating SOX17 expression in ccRCC.
- To elucidate the functional role of SOX17 as a tumor suppressor in ccRCC, including its impact on cell proliferation, migration, and the WNT signaling pathway.
Main Methods:
- Analysis of SOX17 expression using immunohistochemistry (IHC) and real-time PCR in ccRCC tissues and cell lines.
- Assessment of SOX17 promoter methylation via methylation-specific PCR (MSP) and bisulfite genomic sequencing (BGS).
- Functional assays including CCK8, colony formation, wound healing, and Matrigel invasion assays to evaluate SOX17's effect on cell behavior. Luciferase assays were used to study SOX17's interaction with the WNT signaling pathway.
Main Results:
- SOX17 expression was significantly lower in ccRCC tissues compared to adjacent non-malignant tissues.
- DNA promoter methylation of SOX17 was observed in 60% of ccRCC tissues, indicating epigenetic silencing.
- Overexpression of SOX17 suppressed ccRCC cell proliferation, migration, and invasion, and downregulated WNT pathway targets c-myc and cyclinD1.
Conclusions:
- SOX17 is epigenetically silenced through promoter methylation in ccRCC, leading to its downregulation.
- SOX17 functions as a tumor suppressor in ccRCC by inhibiting cell proliferation and migration.
- SOX17 negatively regulates the WNT signaling pathway, contributing to its tumor-suppressive role in ccRCC.
More Related Videos
09:58An Optimized Protocol for Electrophoretic Mobility Shift Assay Using Infrared Fluorescent Dye-labeled Oligonucleotides
Published on: November 29, 2016
07:34The Power of Simplicity: Sea Urchin Embryos as in Vivo Developmental Models for Studying Complex Cell-to-cell Signaling Network Interactions
Published on: February 16, 2017
Related Concept Videos
Canonical Wnt Signaling Pathway
Pleiotropy
Non-Canonical Wnt Signaling Pathways
Epigenetic Regulation
X-chromosome...
Epigenetic Regulation
Inheritance of Chromatin Structures